Home › Therapeutic areas › Cardiovascular › Arrhythmogenic Cardiomyopathy
Arrhythmogenic Cardiomyopathy (2 companies)
Companies with an active program in Arrhythmogenic Cardiomyopathy.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics | CardiovascularNeurology Rare | 1 | Phase 2 | 12 |
| RCKT | Rocket Pharmaceuticals | CardiovascularImmunology Rare | 1 | Approved | 4 |
No companies match.